Drug Type Small molecule drug |
Synonyms INCB-177054, INCB177054 |
Target |
Action inhibitors |
Mechanism DGKA inhibitors(diacylglycerol kinase alpha inhibitors), DGKζ inhibitors(diacylglycerol kinase zeta inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | United States | 30 Jun 2025 | |
| Metastatic Solid Tumor | Phase 2 | United States | 30 Jun 2025 |





